194 related articles for article (PubMed ID: 29064042)
1. Treatment-Induced Neuropathy of Diabetes.
Gibbons CH
Curr Diab Rep; 2017 Oct; 17(12):127. PubMed ID: 29064042
[TBL] [Abstract][Full Text] [Related]
2. Treatment induced neuropathy of diabetes.
Gibbons CH
Auton Neurosci; 2020 Jul; 226():102668. PubMed ID: 32247944
[TBL] [Abstract][Full Text] [Related]
3. Treatment induced neuropathy of diabetes-Long term implications in type 1 diabetes.
Gibbons CH
J Diabetes Complications; 2017 Apr; 31(4):715-720. PubMed ID: 28159476
[TBL] [Abstract][Full Text] [Related]
4. Treatment-Induced Neuropathy in Diabetes (TIND)-Developing a Disease Model in Type 1 Diabetic Rats.
Baum P; Koj S; Klöting N; Blüher M; Classen J; Paeschke S; Gericke M; Toyka KV; Nowicki M; Kosacka J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557206
[TBL] [Abstract][Full Text] [Related]
5. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.
Gibbons CH; Freeman R
Brain; 2015 Jan; 138(Pt 1):43-52. PubMed ID: 25392197
[TBL] [Abstract][Full Text] [Related]
6. Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes.
Gibbons CH; Goebel-Fabbri A
Curr Diab Rep; 2017 Jul; 17(7):48. PubMed ID: 28526993
[TBL] [Abstract][Full Text] [Related]
7. Treatment-Induced Neuropathy of Diabetes (TIND) in Pediatrics: A Case Report and Review of the Literature.
Chandler E; Brown M; Wintergerst K; Doll E
J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31613321
[TBL] [Abstract][Full Text] [Related]
8. No common denominator: Plant-based diets and treatment-induced neuropathy of diabetes.
Storz MA
Med Hypotheses; 2019 Aug; 129():109250. PubMed ID: 31371079
[TBL] [Abstract][Full Text] [Related]
9. Under-recognised paradox of neuropathy from rapid glycaemic control.
Leow MK; Wyckoff J
Postgrad Med J; 2005 Feb; 81(952):103-7. PubMed ID: 15701742
[TBL] [Abstract][Full Text] [Related]
10. [Diabetic neuropathy: therapeutic nihilism is no longer acceptable].
Haslbeck M
MMW Fortschr Med; 2007 May; 149 Suppl 2():24, 26-8, 30. PubMed ID: 17724963
[TBL] [Abstract][Full Text] [Related]
11. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
Albers JW; Herman WH; Pop-Busui R; Feldman EL; Martin CL; Cleary PA; Waberski BH; Lachin JM;
Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
[TBL] [Abstract][Full Text] [Related]
12. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
13. A study of autonomic neuropathy in diabetes mellitus in relation to its metabolic control.
Gupta RC; Chittora MD; Jain A
J Assoc Physicians India; 1995 Jul; 43(7):464-6. PubMed ID: 8713218
[TBL] [Abstract][Full Text] [Related]
14. Murine model and mechanisms of treatment-induced painful diabetic neuropathy.
Nicodemus JM; Enriquez C; Marquez A; Anaya CJ; Jolivalt CG
Neuroscience; 2017 Jun; 354():136-145. PubMed ID: 28476321
[TBL] [Abstract][Full Text] [Related]
15. Treatment-induced neuropathy of diabetes: challenges in diagnosing neuropathic pain, value of sudomotor function testing.
Abdelhamid S; Shabani M; Russjan A; Tarnutzer AA
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967926
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal effects of one-leg standing time on neuropathy outcomes in association with glycemic control in non-elderly patients with type 2 diabetes.
Sugimoto K; Sozu T; Hoshino T; Watanabe Y; Tamura A; Yamazaki T; Ohta S; Suzuki S; Shimbo T
J Diabetes Investig; 2022 Jun; 13(6):1039-1051. PubMed ID: 35044110
[TBL] [Abstract][Full Text] [Related]
17. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM).
Azad N; Emanuele NV; Abraira C; Henderson WG; Colwell J; Levin SR; Nuttall FQ; Comstock JP; Sawin CT; Silbert C; Rubino FA
J Diabetes Complications; 1999; 13(5-6):307-13. PubMed ID: 10765007
[TBL] [Abstract][Full Text] [Related]
18. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Martin CL; Albers JW; Pop-Busui R;
Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.
Pop-Busui R; Lu J; Lopes N; Jones TL;
J Peripher Nerv Syst; 2009 Mar; 14(1):1-13. PubMed ID: 19335534
[TBL] [Abstract][Full Text] [Related]
20. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
